These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20235883)

  • 21. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
    Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
    J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic involvement in lymphangioleiomyomatosis.
    Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
    Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of lymphatics in lymphangioleiomyomatosis.
    Glasgow CG; Taveira-DaSilva A; Pacheco-Rodriguez G; Steagall WK; Tsukada K; Cai X; El-Chemaly S; Moss J
    Lymphat Res Biol; 2009 Dec; 7(4):221-8. PubMed ID: 20143921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
    Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
    Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.
    Baldi BG; Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
    Am J Respir Crit Care Med; 2012 Aug; 186(4):341-8. PubMed ID: 22700863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphangioleiomyomatosis: a clinical update.
    McCormack FX
    Chest; 2008 Feb; 133(2):507-16. PubMed ID: 18252917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).
    Hammes SR; Krymskaya VP
    Horm Cancer; 2013 Apr; 4(2):70-7. PubMed ID: 23184699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
    Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
    Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis].
    Urban T
    Rev Mal Respir; 2007 Jun; 24(6):725-40. PubMed ID: 17632432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
    Sobiecka M
    Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
    Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
    Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging biomarkers of lymphangioleiomyomatosis.
    Nijmeh J; El-Chemaly S; Henske EP
    Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphangioleiomyomatosis.
    Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
    Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary lymphangioleimyomatosis : review and case report].
    Excoffier S; Guinand O; Rochat T
    Rev Med Suisse; 2016 Aug; 12(527):1390-1393. PubMed ID: 28671794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
    Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
    Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
    Koba T; Arai T; Kitaichi M; Kasai T; Hirose M; Tachibana K; Sugimoto C; Akira M; Hayashi S; Inoue Y
    Respirology; 2018 Mar; 23(3):331-338. PubMed ID: 28960664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphangioleiomyomatosis: current and future.
    Mavroudi M; Zarogoulidis P; Katsikogiannis N; Tsakiridis K; Huang H; Sakkas A; Kallianos A; Rapti A; Sarika E; Karapantzos I; Zarogoulidis K
    J Thorac Dis; 2013 Feb; 5(1):74-9. PubMed ID: 23372952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis].
    Lu SH; Tan YS; Xu JF; Sujie A; Bai CX; Zhu XZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):664-9. PubMed ID: 20079279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.